TENAX THERAPEUTICS, INC. Convertible Notes Payable, Current
TENAX THERAPEUTICS, INC. (TENX) had Convertible Notes Payable, Current of $100.16 thousand as of 2015-04-30, per its 10-KT filed 2016-03-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Notes and Loans Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2016-03-14
- 2015-04-30: Convertible Notes Payable, Current $100.16K.
- 2015-01-31: Convertible Notes Payable, Current $151.25K.
- 2014-10-31: Convertible Notes Payable, Current $0.00.
- 2014-07-31: Convertible Notes Payable, Current $16.01K.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2015-04-30 | $100.16K 10-KT · filed 2016-03-14 |
| 2015-01-31 | $151.25K 10-Q · filed 2015-03-17 |
| 2014-10-31 | $0.00 10-Q · filed 2014-12-15 |
| 2014-07-31 | $16.01K 10-Q · filed 2014-09-15 |
| 2014-04-30 | $63.57K 10-KT · filed 2016-03-14 |
| 2014-01-31 | $110.44K 10-Q · filed 2014-03-17 |
| 2013-10-31 | $0.00 10-Q · filed 2013-12-17 |
| 2013-07-31 | $23.17K 10-Q · filed 2013-09-17 |
| 2013-04-30 | $57.54K 10-K · filed 2014-07-29 |
| 2013-01-31 | $7.20K 10-Q · filed 2013-03-18 |
| 2012-10-31 | $7.20K 10-Q · filed 2012-12-14 |
| 2012-07-31 | $7.20K 10-Q · filed 2012-09-19 |
| 2012-04-30 | $7.20K 10-K · filed 2013-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |